Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for Drug-Induced QT Lengthening in Women
NCT03834883Phase 4Completed
- Sponsor
- Indiana University
- Start
- Mar 2019
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of progesterone in long QT syndrome (LQTS), sponsored by Indiana University. Started Mar 2019; status: completed.
02
Drugs
progesterone
03
Conditions
long QT syndrome (LQTS)
Beyond the preview
Go deeper on NCT03834883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03834883.